In This Article:
Vancouver, British Columbia--(Newsfile Corp. - October 19, 2018) - Benchmark Botanics Inc. (CSE: BBT) (the "Company" or "Benchmark") announces the granting of stock options to a director and an officer of the Company for an aggregate of 950,000 stock options of the Company exercisable at C$0.48, being the unit price for each common share of the most recent market price closed on October 19, 2018, effective October 19, 2018. The Options shall expire and terminate on October 18, 2023.
These stock options have been granted in accordance with the Company's Stock Option Plan. Pursuant to this plan, the Company is authorized to grant an aggregate of up to 10% of its issued and outstanding common shares on a rolling basis. Immediately following this award of stock options the Company has issued and outstanding stock options for 9,563,333 common shares of the Company and there were 4,608,131 stock options of the Company available for future grant.
ON BEHALF OF THE BOARD OF
BENCHMARK BOTANICS INC.
/s/ "William Ying"
William Ying
Chief Executive Officer
For Further Information
Investor Relations
Benchmark Botanics, Inc.
Email: office@bbtinc.ca
Tel: 604-238-0005
For further information, please visit the Company's website at www.benchmarkbotanics.com or the Company's profile at www.sedar.com.
If you would like to be added to Benchmark Botanics' news distribution list, please send your email address to office@bbtinc.ca.
The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this release.
FORWARD LOOKING INFORMATION
This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. More particularly and without limitation, the news release contains forward-looking statements and information relating to Company's corporate strategy. The forward-looking statements and information are based on certain key expectations and assumptions made by management of the Company, including, without limitation, the Company's ability to carry out its business plan. Although management of the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on the forward-looking statements and information since no assurance can be given that they will prove to be correct.